Format

Send to

Choose Destination
J Int Med Res. 2013 Feb;41(1):20-30. doi: 10.1177/0300060513475965. Epub 2013 Jan 23.

Plasmid-mediated quinolone resistance--current knowledge and future perspectives.

Author information

1
Department of Respiratory Diseases, Chinese PLA General Hospital, Beijing, China.

Abstract

Quinolones are a group of antimicrobial agents that were serendipitously discovered as byproducts of the synthesis of chloroquine. Chemical modifications, such as the addition of fluorine or piperazine, resulted in the synthesis of third- and fourth-generation fluoroquinolones, with broad-spectrum antimicrobial actions against aerobic or anaerobic, Gram-positive or Gram-negative bacteria. The efficacy and consequent widespread use of quinolones and fluoroquinolones has led to a steady global increase in resistance, mediated via gene mutations, alterations in efflux or cell membranes and plasmid-conferred resistance. The first plasmid-mediated quinolone resistance gene, qnrA1, was detected in 1998. Since then, many other genes have been identified and the underlying mechanisms of resistance have been elucidated. This review provides an overview of quinolone resistance, with particular emphasis on plasmid-mediated resistance.

PMID:
23569126
DOI:
10.1177/0300060513475965
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center